EUVIMEDEUVIMED entdecken
Crossref

Yangxue Qingnao Wan ameliorates cognitive impairment in scopolamine-induced AD mice via modulating neuropeptide signaling pathways and suppressing neuroinflammation

Xiaolian Zhang, Jinna Yang, Meng Xiao, Jieqi Zhang, Chuipu Cai, Wentao Wei, Shuhuan Fang, Xiaxia Ren, Kaimin Guo, Pengcheng Yang, Wenjia Wang, Yunhui Hu und 1 weitere

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2025.157602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Xiaolian Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Gu…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Cognitive Dysfunction, Alzheimer Disease, Neuroprotective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Key Research and Development Program of China, Natural Science Foundation of Tianjin Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Alzheimer's disease (AD), a fatal neurodegenerative disorder with increasing incidence worldwide, remains a significant therapeutic challenge. Yangxue Qingnao Wan (YXQNW), a traditional Chinese medicine, has shown promise in AD treatment. However, its intricate mechanism of action necessitates further investigation. Clarifying YXQNW's active components and molecular targets could advance novel therapeutic strategies for AD. PURPOSE: This research aimed to identify anti-AD bioactive compounds in YXQNW and investigate their mechanisms using transcriptomic profiling and network proximity analysis. METHODS: The neuroprotective effects of YXQNW were evaluated in scopolamine (SCOP)-induced AD mice through behavioral tests, histopathological assessments, and biochemical analyses (acetylcholinesterase activity, oxidative stress markers and pro-inflammatory cytokines). Transcriptomic analysis was employed to explore YXQNW's regulatory targets and pathways. Key targets were validated by RT-qPCR, immunofluorescence (IF) and Western blot. Network proximity was used to predict anti-AD components, followed by in vitro mechanism validation in SCOP-induced HT22 cells using Gpr139 agonist and antagonist. RESULTS: YXQNW ameliorated spatial memory deficits, cholinergic dysfunction, oxidative stress, and neuroinflammation in vivo. Transcriptomics analysis uncovered significantly modulation of neuropeptide signaling pathways, including upregulation of Gpr139 and downregulation of Gal/Galr1, mitigating cognitive impairment. Network proximity identified 8 anti-AD components, with Palmatine, Ligustilide, and Obtusifolin demonstrating efficacy in reducing oxidative stress, inflammation, and neuronal damage in vitro, and could also regulate the expression of neuropeptides. Moreover, Palmatine inhibits neuroinflammation via regulating Gpr139 protein expression. CONCLUSIONS: YXQNW alleviates AD-like pathology by restoring cholinergic homeostasis, suppressing oxidative stress and neuroinflammation, and regulating neuropeptide signaling. And its active ingredient (Palmatine) can inhibit inflammatory response by regulating the expression of Gpr139 protein. This study supports YXQNW's clinical application and provides novel insights for AD drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalCognitive DysfunctionAlzheimer DiseaseNeuroprotective AgentsAnimalsScopolamineMiceSignal TransductionMaleNeuroinflammatory DiseasesOxidative StressDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

Alzheimer's diseaseInflammatory responseNetwork proximityNeuropeptideTranscriptomicsYangxue Qingnao Wan

Substanzen

ScopolamineDrugs, Chinese HerbalNeuroprotective Agents

Autor:innen und Institutionen

  • State Key Laboratory of Traditional Chinese Medicine Syndrome, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
  • Tianjin Tasly Digital Intelligence Chinese Medicine Technology Co., Ltd., Tianjin 300410, China; State Key Laboratory of Chinese Medicine Modernization, Tianjin 300193, China; Tasly Biopharmaceuticals Co.,Ltd., Tianjin…
  • Department of Computer Science, Key Laboratory of Intelligent Manufacturing Technology of Ministry of Education, Shantou University, Shantou, 515000, China.
  • Tianjin Tasly Digital Intelligence Chinese Medicine Technology Co., Ltd., Tianjin 300410, China; Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • State Key Laboratory of Traditional Chinese Medicine Syndrome, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: fangjs@gzucm.edu.cn.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Key Research and Development Program of China
  • Natural Science Foundation of Tianjin Municipality

Zitieren

APA

Zhang, X., Yang, J., Xiao, M., Zhang, J., Cai, C., Wei, W., Fang, S., Ren, X., Guo, K., Yang, P., Wang, W., Hu, Y., & Fang, J. (2026). Yangxue Qingnao Wan ameliorates cognitive impairment in scopolamine-induced AD mice via modulating neuropeptide signaling pathways and suppressing neuroinflammation. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157602

Vancouver

Zhang X, Yang J, Xiao M, Zhang J, Cai C, Wei W, et al. Yangxue Qingnao Wan ameliorates cognitive impairment in scopolamine-induced AD mice via modulating neuropeptide signaling pathways and suppressing neuroinflammation. Phytomedicine. 2026. doi:10.1016/j.phymed.2025.157602

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaolian and Yang, Jinna and Xiao, Meng and Zhang, Jieqi and Cai, Chuipu and Wei, Wentao and Fang, Shuhuan and Ren, Xiaxia and Guo, Kaimin and Yang, Pengcheng and Wang, Wenjia and Hu, Yunhui and Fang, Jiansong},
  title = {Yangxue Qingnao Wan ameliorates cognitive impairment in scopolamine-induced AD mice via modulating neuropeptide signaling pathways and suppressing neuroinflammation},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2025.157602}
}
Kostenlos starten →